Close

Ampio Pharma (AMPE), Paladin (ENDP) Enter Exclusive Agreement for Zertane

April 10, 2014 8:04 AM EDT Send to a Friend
Ampio Pharmaceuticals, Inc. (AMEX: AMPE) announced that its wholly-owned subsidiary Vyrix Pharmaceuticals, a specialty pharmaceutical company focused on developing and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login